114 results
Page 2 of 6
424B5
awlgi7r
2 Dec 22
Prospectus supplement for primary offering
6:31am
6-K
EX-99.1
aqekihp
29 Nov 22
RedHill Biopharma Announces Q3/22 Results and Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt
8:05am
6-K
EX-99.2
xjbuv94ybwo bw
29 Nov 22
RedHill Biopharma Announces Q3/22 Results and Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt
8:05am
6-K
EX-99.2
33awx4jp z6
7 Nov 22
RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
9:46am
6-K/A
EX-99.2
kd5zjtdg68kq0
7 Nov 22
RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
9:34am
6-K
EX-99.1
beb2k8r
4 Nov 22
RedHill Presents New Talicia® Data Analyses at Obesity Week 2022
7:02am
6-K
EX-99.1
kq14yezwr
26 Oct 22
RedHill Presents New Talicia® and Movantik® Data Analyses
7:02am
6-K
EX-99.1
z9qob8yr8e7ql
12 Jul 22
RedHill Announces New H. pylori and COVID-19 Data
8:03am
6-K
EX-99.1
jwpt8g8aemxj swvsc
25 May 22
RedHill Presents New Talicia® Data Analyses at DDW 2022
9:17am
424B5
hrtlfqt
11 May 22
Prospectus supplement for primary offering
8:47am
6-K
EX-99.1
22xz9
17 Mar 22
RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results
8:04am
6-K
EX-99.1
jmqmzl
6 Jan 22
Agreement for Talicia® for the United Arab Emirates
9:18am
6-K
EX-99.1
twrg9w
9 Dec 21
Current report (foreign)
7:01am
6-K
EX-99.1
do9e1awpu lq6wbqsm72
2 Dec 21
Current report (foreign)
7:01am
424B5
tmb0ru5c
22 Nov 21
Prospectus supplement for primary offering
4:30pm
424B5
jtqkzr2h jrut
18 Nov 21
Prospectus supplement for primary offering
4:17pm
6-K
EX-99.1
qwcmnwiut147a0xk
25 Oct 21
Current report (foreign)
7:03am
6-K
EX-1
0c0wj7mdcgm
12 Oct 21
RedHill Biopharma Announces New U.S. Patent Covering
7:05am
6-K
EX-1
ru30orsl2buz 2y5
6 Oct 21
RedHill Biopharma’s Talicia® added to Medi-Cal Contract
7:02am